ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,018.39
      -0.34%
      US Tech 100
      16,954.40
      -0.17%
      Dow Jones
      37,903.29
      0.23%
      Brent Oil
      84.005
      0.56%
      Bitcoin
      57,498.11
      -1.27%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. MedTech Acquisition Corporation (MTAC)

      7. MedTech Acquisition Corporation (MTAC) News

      MTAC

      MedTech Acquisition (MTAC)

      MedTech Acquisition Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MTAC
      DateTimeSourceHeadlineSymbolCompany
      08/02/20235:00PMBusiness WireMedTech Acquisition Corporation Adjourns Special Meeting of StockholdersNASDAQ:MTACMedTech Acquisition Corporation
      06/27/20234:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MTACMedTech Acquisition Corporation
      06/22/20235:07PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:MTACMedTech Acquisition Corporation
      06/15/20235:14PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MTACMedTech Acquisition Corporation
      06/15/20234:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
      06/12/20237:06AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
      06/12/20237:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
      06/12/20237:00AMBusiness WireTriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual MeetingNASDAQ:MTACMedTech Acquisition Corporation
      06/08/20237:01AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
      06/08/20237:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
      05/24/20234:29PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MTACMedTech Acquisition Corporation
      05/15/20237:01AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
      05/15/20237:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
      04/21/20235:12PMEdgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:MTACMedTech Acquisition Corporation
      04/20/20237:07AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
      04/20/20237:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
      04/20/20237:00AMBusiness WireTriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver MetastasesNASDAQ:MTACMedTech Acquisition Corporation
      04/05/20234:32PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
      04/05/20234:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
      03/22/20234:17PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:MTACMedTech Acquisition Corporation
      03/08/20234:34PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
      03/08/20234:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
      02/21/20237:08AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
      02/21/20237:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
      02/21/20237:00AMBusiness WireTriSalus Life Sciences Appoints James Alecxih to Lead Device Technology BusinessNASDAQ:MTACMedTech Acquisition Corporation
      02/16/20237:08AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
      02/16/20237:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
      02/09/20235:29PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MTACMedTech Acquisition Corporation
      02/09/20239:24AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MTACMedTech Acquisition Corporation
      02/08/20232:11PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MTACMedTech Acquisition Corporation
       Showing the most relevant articles for your search:NASDAQ:MTAC